Dolby Laboratories (NYSE:DLB) Issues Quarterly Earnings Results, Beats Expectations By $0.06 EPS

Dolby Laboratories (NYSE:DLBGet Free Report) announced its quarterly earnings data on Thursday. The electronics maker reported $1.37 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.31 by $0.06, FiscalAI reports. The business had revenue of $395.63 million for the quarter, compared to analysts’ expectations of $385.80 million. Dolby Laboratories had a return on equity of 11.48% and a net margin of 17.85%.The firm’s quarterly revenue was up 7.0% compared to the same quarter last year. During the same period in the previous year, the business posted $1.34 EPS. Dolby Laboratories updated its FY 2026 guidance to 4.300-4.450 EPS and its Q3 2026 guidance to 0.560-0.710 EPS.

Here are the key takeaways from Dolby Laboratories’ conference call:

  • Q2 results met company guidance with $396M revenue and $1.37 non‑GAAP EPS; management reaffirmed full‑year guidance of $1.4B–$1.45B revenue and $4.30–$4.45 EPS while reporting $93M operating cash flow, a $65M buyback and ~$675M cash and investments.
  • Broad content adoption is accelerating demand — major social platforms (Meta, Douyin), top music artists, marquee sports events (Super Bowl, Olympics, F1) and the top domestic films are streaming or produced in Dolby Atmos and Dolby Vision, supporting device and platform adoption.
  • Automotive is a notable growth driver with wins from BMW, BYD (Denza), Lexus, NIO and Hyundai’s IONIQ (4‑channel Atmos), and the company says it is moving from premium to deeper, mass‑market vehicle lineups.
  • New monetization initiatives — the Video Distribution patent pool now includes ~40 licensors and a growing licensee pipeline, and Dolby OptiView added customers (Genius Sports, William Hill) targeting personalized live sports experiences, but these programs are early in commercial ramp.
  • Macro and product‑mix headwinds persist — memory pricing and timing affected mobile and PC (mobile down 6% this quarter), contributing to quarterly volatility even though management expects mid‑single‑digit full‑year growth in those end markets.

Dolby Laboratories Stock Performance

DLB traded down $6.66 on Friday, reaching $57.48. The company had a trading volume of 2,137,252 shares, compared to its average volume of 482,138. The business has a 50 day simple moving average of $62.58 and a 200 day simple moving average of $64.55. The company has a market cap of $5.49 billion, a price-to-earnings ratio of 23.18 and a beta of 0.86. Dolby Laboratories has a 52-week low of $55.73 and a 52-week high of $78.28.

Dolby Laboratories Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, May 20th. Stockholders of record on Tuesday, May 12th will be given a $0.36 dividend. This represents a $1.44 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Tuesday, May 12th. Dolby Laboratories’s dividend payout ratio (DPR) is 58.06%.

Key Headlines Impacting Dolby Laboratories

Here are the key news stories impacting Dolby Laboratories this week:

  • Positive Sentiment: Q2 results topped Street estimates — Dolby reported EPS of $1.37 and revenue of roughly $395.6M, driven by licensing strength, higher broadcast demand and continued Dolby Atmos adoption. This topline beat supports near‑term growth narratives. Dolby Q2 Earnings Top Estimates on Licensing Strength, Revenues Up Y/Y
  • Positive Sentiment: Management raised FY‑2026 outlook — Dolby lifted full‑year EPS guidance to $4.30–$4.45 (above consensus) and gave a revenue range that implies mid‑single‑digit growth for the year, supporting longer‑term earnings expectations. Dolby Laboratories Reports Second Quarter 2026 Financial Results
  • Neutral Sentiment: Quarterly dividend declared — Dolby set a $0.36 quarterly dividend (yield ~2.5%), payable May 20 with an ex‑dividend date of May 12. This supports income investors but is expected and not a surprise.
  • Neutral Sentiment: Earnings materials available — The full earnings release and call transcript are published for more detail on segment trends, customer wins and product adoption; useful for digging into assumptions behind guidance. Dolby Q2 2026 Earnings Call Transcript
  • Negative Sentiment: Weak Q3 guidance drove the sell‑off — Dolby guided Q3 EPS of $0.56–$0.71 and revenue of $295–$325M, both materially below consensus (Q3 revenue guidance ~ $343M and EPS ~ $0.92), signaling near‑term demand variability and prompting investor concern.
  • Negative Sentiment: Cash‑flow and other operational flags — Third‑party summaries highlighted a sharp drop in operating cash flow year‑over‑year and a modest decline in cash balances, raising questions about near‑term cash generation despite GAAP profitability. Dolby Laboratories (DLB) Stock Falls on Q2 2026 Earnings
  • Negative Sentiment: Insider and institutional activity noted — Recent reporting flagged substantial insider selling and some large institutional position reductions, which can add downward pressure on sentiment if sustained. Dolby Laboratories (DLB) Stock Falls on Q2 2026 Earnings

Insider Buying and Selling

In related news, CAO Ryan Nicholson sold 2,667 shares of the firm’s stock in a transaction that occurred on Friday, February 13th. The shares were sold at an average price of $66.38, for a total value of $177,035.46. Following the sale, the chief accounting officer directly owned 36,956 shares of the company’s stock, valued at $2,453,139.28. This trade represents a 6.73% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through the SEC website. Also, SVP Shriram Revankar sold 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 17th. The shares were sold at an average price of $66.14, for a total transaction of $198,420.00. Following the completion of the sale, the senior vice president directly owned 83,218 shares in the company, valued at $5,504,038.52. This represents a 3.48% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Company insiders own 37.93% of the company’s stock.

Institutional Investors Weigh In On Dolby Laboratories

Institutional investors and hedge funds have recently bought and sold shares of the stock. Aquatic Capital Management LLC purchased a new stake in Dolby Laboratories in the third quarter valued at approximately $56,000. iSAM Funds UK Ltd purchased a new stake in Dolby Laboratories in the third quarter valued at approximately $68,000. Quarry LP raised its stake in Dolby Laboratories by 1,486.7% in the fourth quarter. Quarry LP now owns 1,190 shares of the electronics maker’s stock valued at $76,000 after purchasing an additional 1,115 shares in the last quarter. Advisory Services Network LLC purchased a new stake in Dolby Laboratories in the third quarter valued at approximately $102,000. Finally, US Bancorp DE raised its stake in Dolby Laboratories by 31.3% in the third quarter. US Bancorp DE now owns 1,429 shares of the electronics maker’s stock valued at $103,000 after purchasing an additional 341 shares in the last quarter. 58.56% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities analysts have recently weighed in on the stock. Weiss Ratings reiterated a “hold (c-)” rating on shares of Dolby Laboratories in a research note on Friday, March 27th. Wall Street Zen downgraded shares of Dolby Laboratories from a “buy” rating to a “hold” rating in a research note on Saturday, January 31st. Rosenblatt Securities reiterated a “buy” rating and issued a $85.00 target price on shares of Dolby Laboratories in a research note on Friday, January 30th. Finally, Barrington Research reiterated an “outperform” rating and issued a $90.00 target price on shares of Dolby Laboratories in a research note on Monday, April 27th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the stock. According to data from MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $90.75.

Check Out Our Latest Analysis on DLB

About Dolby Laboratories

(Get Free Report)

Dolby Laboratories, Inc is a global leader in audio and imaging technologies, specializing in the development, licensing and deployment of solutions that enhance entertainment and communications experiences. The company’s core business revolves around creating advanced audio codecs, noise reduction systems and spatial sound technologies for a wide range of applications, including cinema, broadcast, gaming, streaming and personal devices. Dolby’s licensing model enables consumer electronics manufacturers, content creators and service providers to integrate its technologies into products such as televisions, smartphones, home theater systems and set-top boxes.

Among its flagship innovations are Dolby Atmos, an immersive audio format that delivers three-dimensional soundscapes for theaters and home systems; Dolby Digital and Dolby Digital Plus, widely adopted audio compression formats for broadcast and streaming; and Dolby Vision, a high-dynamic-range imaging technology that expands color, contrast and brightness in displays.

Read More

Earnings History for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.